PD-1/PD-L1 mediated T-cell dysfunction in CLL is not absolute and can be at least partially reversed in vivo by the immune-modulatory drug lenalidomide

Volume
37
Pagination
236 - 236
Journal
ONCOLOGY RESEARCH AND TREATMENT
ISSN
2296-5270
Metadata
Show full item record
Authors
McClanahan, F; Riches, JC; Miller, S; Ghazaly, E; Day, W; Capasso, M; Gribben, J
URI
http://qmro.qmul.ac.uk/jspui/handle/123456789/6568
Collections